Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound MEDLINE
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for Windows
(TUR)
3,469 results
  • Head-to-head drug comparisons in multiple sclerosis: Urgent action needed. [Review]
    Neurology 2019Tur C, Kalincik T, … Montalban X
  • Disease-modifying drugs are changing the natural history of multiple sclerosis (MS). However, currently available clinical trial data are insufficient to develop accurate personalized treatment algorithms to assign the best possible treatment to each person with MS according to disease features, treatment history, and comorbidities. Such accurate algorithms would require the presence of numerous …
  • Genome-Wide Association Study of White Blood Cell Counts in Patients With Ischemic Stroke. [Journal Article]
    Stroke 2019; :STROKEAHA119026593Torres-Aguila NP, Carrera C, … Fernandez-Cadenas I
  • Background and Purpose- Immune cells play a key role in the first 24h poststroke (acute phase), being associated with stroke outcome. We aimed to find genetic risk factors associated with leukocyte counts during the acute phase of stroke. Methods- Ischemic stroke patients with leukocyte counts data during the first 24h were included. Genome-wide association study and gene expression studies were …
New Search Next